AnandRathi

Concord Biotech Ltd Fundamental Analysis

Last Updated Date: 21 Sept 2026
₹1,580.45
+86.55 (+5.79%)

Concord Biotech Ltd (Concord Biotech) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹15,629 crore.

Concord Biotech Ltd Overview

Market cap₹15,629 Crs
Volume20,325
Prev. Close₹1,493.90
Year range₹987.05 - ₹1,702.10
ISININE338H01029

Concord Biotech Ltd Fundamentals

ROCE(TTM)17.41%
P/E Ratio (TTM)55.43
P/B Ratio7.74
Debt to Equity0.00
ROE13.03%
EPS (TTM)27.18
Dividend Yield0.51%
Book Value193.06
Profit Margin25.58%
Operating Margin29.48%

Concord Biotech Ltd Historical Performance

1 Month Return-4.65%
6 Month Return30.88%
3 Year Return48.91%
3 Month Return11.32%
1 Year Return-9.78%
5 Year Return-

Concord Biotech Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research